Transdermal Patch: How Medicated Plasters Work, Becoming a Mainstay of Modern Therapy
Pharmaceutical dosage forms designed to deliver drugs through the skin, also known as topical dosage forms, are increasingly gaining attention in modern healthcare and pharmaceutical fields. One innovation that has attracted considerable interest is the transdermal patch, a drug delivery system in the form of a patch applied to the skin’s surface.
This dosage form offers several advantages over oral and parenteral administration methods, such as the ability to avoid first-pass metabolism in the liver and prevent drug degradation caused by exposure to gastric acid. In addition, transdermal patches enable the gradual, stable, and controlled release of active substances over an extended period, maintaining optimal drug concentrations in the body. The ease of use and comfort perceived by patients are also among the main reasons why this dosage form is becoming increasingly popular, particularly for long-term therapy.
- How Does a Transdermal Patch Release Drugs into the Body?
- Transdermal Patch Formulation Using Caffeine
- Transdermal Patches as the Future
How Does a Transdermal Patch Release Drugs into the Body?
When applied to the skin, a transdermal patch can relieve pain by delivering the drug into the bloodstream through diffusion and partition processes. Initially, the drug stored in the drug layer is released and allowed to partition into the stratum corneum layer of the skin.
In this layer, the drug undergoes diffusion and subsequently partitions into the underlying skin layers, continuing this process until it reaches the dermis. In the dermis, which is rich in blood vessels, the drug is absorbed into the capillary blood vessels and enters systemic circulation.
Once in the bloodstream, the drug is distributed throughout the body and transported to the target tissue responsible for the pain. At this site, the drug exerts its therapeutic action, thereby alleviating pain.
Transdermal Patch Formulation Using Caffeine
One application of transdermal patches is the caffeine patch, which is formulated to deliver caffeine gradually and steadily over a specific period, serving as an alternative to consuming coffee or other caffeinated beverages. This product can be particularly beneficial for individuals seeking to reduce their intake of coffee or caffeinated drinks while still experiencing the stimulating effects of caffeine.
Transdermal Patches as the Future
The utilization of transdermal patches as an alternative non-oral dosage form offers various advantages that align with the needs of modern therapy, including enhanced patient comfort, reduced gastrointestinal side effects, and more stable and controlled drug release. As a non-invasive drug delivery system, transdermal patches have also been shown to improve patient adherence to treatment, especially in long-term therapies.
Consequently, transdermal patches hold the potential to become a future dosage form that is not only promising in terms of pharmaceutical technology but also supportive of more personalized and sustainable therapeutic approaches. Moving forward, further research is needed to optimize formulations and clinically validate their effectiveness across diverse patient populations.
Want to ensure the safety, stability, and effectiveness of your transdermal patch or topical product formulation?
IML Research provides stability testing, drug release testing, efficacy testing, and safety testing to support your product development with comprehensive and reliable scientific data. Contact the IML Research team to ensure your product meets the highest quality standards before entering the market.
References :
Vasandiya, K., Khan, S., Pathak, D., & Pathan, M. (2025). Caffeine transdermal patches. International Journal of Emerging Technologies and Innovative Research, 5(3), 197–205. https://www.iciset.in/Paper2082.pdf.Veryser, L., Boonen, J., Mehuys, E., Roche, N., Remon, J.-P., Peremans, K., Burvenich, C., & De Spiegeleer, B. (2013). Transdermal Evaluation of Caffeine in Different Formulations and Excipients. Journal of Caffeine Research, 3(1). https://doi.org/10.1089/jcr.2013.0002.
